Skip to content

Rabeprazole D4

Rabeprazole D4

Product Description
CAT No.
ALN-R006D01
CAS No.
934295-48-4
Mol. F.
C18H17D4N3O3S
Mol. Wt.
363.5
Stock
Please Inquire
RFQ
Chemical Name : 2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole-4,5,6,7-d4
Smiles : O=[S](C(NC1=C(C([2H])=C2[2H])[2H])=NC1=C2[2H])CC(N=CC=C3OCCCOC)=C3C
Inchi : InChI=1S/C21H25N3O2S.C4H4O4/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21;5-3(6)1-2-4(7)8/h1-8,25H,9-16H2;1-2H,(H,5,6)(H,7,8)/b;2-1+/i14D2,16D2;

Identification, isolation and characterization of new impurity in rabeprazole sodium

P. SreenivasaRao, Uttam KumarRay, P. BadarinadhGupta, D.V.N. SrinivasaRao, AminulIslam, PradeepRajput, K.MukkantinJournal of Pharmaceutical and Biomedical Analysis Volume 52, Issue 4, 1 August 2010, Pages 620-624

Development and validation of a stability indicating hplc method for the estimation of rabeprazole impurities in pharmaceutical dosage forms by design of experiments

T.v. raghava raju, s.raja kumar1, i.mrutyunjaya rao, n.someswara rao – Asian J Pharm Clin Res, Vol 6, Suppl4, 2013, 43-51

Identification and characterization of stressed degradation products of rabeprazole using LC-ESI/MS/MS and 1H-NMR experiments: in vitro toxicity evaluation of major degradation products

Murali Mohan Bhandi,a\xa0\xa0 Roshan M. Borkar,a\xa0\xa0 G. Shankar,a\xa0\xa0 Snehal Raut,b\xa0\xa0 Narayana Nageshc\xa0 and\xa0 R. Srinivas

Request For Quotation